Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts have?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has 230 citations in the OpenAlex counts ScholarIQ stores.
When was Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts published?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has 2018 year in the ScholarIQ index.
What is the open-access status of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts has hybrid oa status in the ScholarIQ index.
What is the DOI of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The DOI for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.
What is the PMID of Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The PMID for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.
What is the OpenAlex record for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts?
The OpenAlex for Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts is on the source record.